167 related articles for article (PubMed ID: 20374627)
1. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.
Aquaro GD; Positano V; Pingitore A; Strata E; Di Bella G; Formisano F; Spirito P; Lombardi M
J Cardiovasc Magn Reson; 2010 Apr; 12(1):21. PubMed ID: 20374627
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
[TBL] [Abstract][Full Text] [Related]
3. Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy.
Mikami Y; Kolman L; Joncas SX; Stirrat J; Scholl D; Rajchl M; Lydell CP; Weeks SG; Howarth AG; White JA
J Cardiovasc Magn Reson; 2014 Oct; 16(1):85. PubMed ID: 25315701
[TBL] [Abstract][Full Text] [Related]
4. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
[TBL] [Abstract][Full Text] [Related]
5. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
6. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
[TBL] [Abstract][Full Text] [Related]
7. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
[TBL] [Abstract][Full Text] [Related]
8. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
9. High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young.
Österberg AW; Östman-Smith I; Jablonowski R; Carlsson M; Green H; Gunnarsson C; Liuba P; Fernlund E
Pediatr Cardiol; 2021 Mar; 42(3):492-500. PubMed ID: 33515326
[TBL] [Abstract][Full Text] [Related]
10. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy - a prospective clinical cardiovascular magnetic resonance trial.
Muehlberg F; Arnhold K; Fritschi S; Funk S; Prothmann M; Kermer J; Zange L; von Knobelsdorff-Brenkenhoff F; Schulz-Menger J
J Cardiovasc Magn Reson; 2018 Feb; 20(1):13. PubMed ID: 29458430
[TBL] [Abstract][Full Text] [Related]
13. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
White SK; Sado DM; Fontana M; Banypersad SM; Maestrini V; Flett AS; Piechnik SK; Robson MD; Hausenloy DJ; Sheikh AM; Hawkins PN; Moon JC
JACC Cardiovasc Imaging; 2013 Sep; 6(9):955-62. PubMed ID: 23582361
[TBL] [Abstract][Full Text] [Related]
14. Texture analysis and machine learning of non-contrast T1-weighted MR images in patients with hypertrophic cardiomyopathy-Preliminary results.
Baeßler B; Mannil M; Maintz D; Alkadhi H; Manka R
Eur J Radiol; 2018 May; 102():61-67. PubMed ID: 29685546
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium free cardiovascular magnetic resonance with 2-point Cine balanced steady state free precession.
Stromp TA; Leung SW; Andres KN; Jing L; Fornwalt BK; Charnigo RJ; Sorrell VL; Vandsburger MH
J Cardiovasc Magn Reson; 2015 Oct; 17():90. PubMed ID: 26520782
[TBL] [Abstract][Full Text] [Related]
16. Distribution of Hypertrophy and Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy.
Windram JD; Benson LN; Dragelescu A; Yoo SJ; Mertens L; Wong D; Grosse-Wortmann L
Congenit Heart Dis; 2015; 10(6):E258-67. PubMed ID: 26193909
[TBL] [Abstract][Full Text] [Related]
17. Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients.
Wang C; Zheng J; Sun J; Wang Y; Xia R; Yin Q; Chen W; Xu Z; Liao J; Zhang B; Gao F
J Cardiol; 2015 Dec; 66(6):520-6. PubMed ID: 25981868
[TBL] [Abstract][Full Text] [Related]
18. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.
Ellims AH; Iles LM; Ling LH; Hare JL; Kaye DM; Taylor AJ
J Cardiovasc Magn Reson; 2012 Oct; 14(1):76. PubMed ID: 23107451
[TBL] [Abstract][Full Text] [Related]
19. Correlation of electrocardiographic changes and myocardial fibrosis in patients with hypertrophic cardiomyopathy detected by cardiac magnetic resonance imaging.
Song BG; Yang HS; Hwang HK; Kang GH; Park YH; Chun WJ; Oh JH
Clin Cardiol; 2013 Jan; 36(1):31-5. PubMed ID: 23070984
[TBL] [Abstract][Full Text] [Related]
20. Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
Rudolph A; von Knobelsdorff-Brenkenhoff F; Wassmuth R; Prothmann M; Utz W; Schulz-Menger J
J Magn Reson Imaging; 2014 May; 39(5):1153-60. PubMed ID: 24151119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
